Cover image of the article: Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis

Image Credit:Hepat Mon

Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis

Authors

Roxana Sirli1,*, Ioan Sporea2
1Department of Gastroenterology, University of Medicine and Pharmacy, roxanasirli@gmail.com, Romania
2Department of Hepatology, University of Medicine and Pharmacy, Romania
*Corresponding Author: Department of Gastroenterology, University of Medicine and Pharmacy, roxanasirli@gmail.com, Romania. Tel: +40-723537039. Fax: +40-256488003. Email: roxanasirli@gmail.com

Hepatitis Monthly:Vol. 11, issue 7; 560-561
Published online:Jul 31, 2011
Article type:Letter
Received:Apr 09, 2011
Accepted:Apr 15, 2011
How to Cite:Sirli R, Sporea I. Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis. Hepat Mon. 2011;11(7):. doi:

Abstract

This article does not have abstract.

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Omid Abedian,
Abolghasem Ajami,
Farshideh Abedian,
Araz Mirabi,
Ali-Reza Khalilian,
Hana Saffar
,et al.

Abedian O, Ajami A, Abedian F, Mirabi A, Khalilian A, et al. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6035

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Michael Adler

Adler M. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(7):. doi:

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Seyed Mohammadmehdi Hosseini Moghaddam

Hosseini Moghaddam SM. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(8):. doi: https://doi.org/10.5812/kowsar.1735143X.770

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Melda Ulusoy,
Gulgun Akkoclu,
Ayhan Gozaydin,
Sukran Kose

Ulusoy M, Akkoclu G, Gozaydin A, Kose S. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2010;10(3):. doi:

31
May
2011
Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?

Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?

Hadi Parsian

Parsian H. Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?. Hepat Mon. 2011;11(5):. doi:

More by these authors

Roxana SirliPubMedScholar
Ioan SporeaPubMedScholar
Share
Cited by
Metrics